Glenn Wilkins - Monday, February 24, 2025 Medexus Pharmaceuticals 09:41 AM EST - Medexus Pharmaceuticals : Announced that GRAFAPEX™ (treosulfan) for Injection is now commercially available in the United States. Medexus Pharmaceuticals shares T.MDP are trading unchanged at $2.87.